PortfoliosLab logoPortfoliosLab logo
CLDX vs. GRBK
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CLDX vs. GRBK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Celldex Therapeutics, Inc. (CLDX) and Green Brick Partners, Inc. (GRBK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CLDX achieves a 23.01% return, which is significantly higher than GRBK's 17.46% return. Over the past 10 years, CLDX has underperformed GRBK with an annualized return of -6.50%, while GRBK has yielded a comparatively higher 26.22% annualized return.


CLDX

1D
3.02%
1M
8.72%
YTD
23.01%
6M
22.52%
1Y
62.98%
3Y*
-1.99%
5Y*
2.17%
10Y*
-6.50%

GRBK

1D
-1.35%
1M
10.96%
YTD
17.46%
6M
16.11%
1Y
21.19%
3Y*
10.45%
5Y*
27.27%
10Y*
26.22%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CLDX vs. GRBK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CLDX
Celldex Therapeutics, Inc.
23.01%7.48%-36.28%-11.02%15.35%120.55%685.65%-24.88%-93.03%-19.77%
GRBK
Green Brick Partners, Inc.
17.46%10.92%8.76%114.36%-20.11%32.10%100.00%58.56%-35.93%12.44%

Correlation

The correlation between CLDX and GRBK is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.22

Correlation (5Y)
Calculated over the trailing 5-year period

0.27

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Mar 10, 2008

0.16

The correlation between CLDX and GRBK shifts across timeframes, from 0.16 (all time) to 0.27 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CLDX:

$2.22B

GRBK:

$3.20B

EPS

CLDX:

-$4.27

GRBK:

$6.86

PS Ratio

CLDX:

2.71K

GRBK:

1.56

PB Ratio

CLDX:

4.87

GRBK:

1.71

Total Revenue (TTM)

CLDX:

$820.00K

GRBK:

$2.06B

Gross Profit (TTM)

CLDX:

$805.00K

GRBK:

$615.58M

EBITDA (TTM)

CLDX:

-$216.32M

GRBK:

$397.80M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CLDX vs. GRBK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLDX
CLDX Risk / Return Rank: 7777
Overall Rank
CLDX Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
CLDX Sortino Ratio Rank: 7676
Sortino Ratio Rank
CLDX Omega Ratio Rank: 7171
Omega Ratio Rank
CLDX Calmar Ratio Rank: 8080
Calmar Ratio Rank
CLDX Martin Ratio Rank: 8181
Martin Ratio Rank

GRBK
GRBK Risk / Return Rank: 5959
Overall Rank
GRBK Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
GRBK Sortino Ratio Rank: 5959
Sortino Ratio Rank
GRBK Omega Ratio Rank: 5555
Omega Ratio Rank
GRBK Calmar Ratio Rank: 6161
Calmar Ratio Rank
GRBK Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLDX vs. GRBK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Celldex Therapeutics, Inc. (CLDX) and Green Brick Partners, Inc. (GRBK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CLDXGRBKDifference
Sharpe ratioReturn per unit of total volatility

+0.52

Sortino ratioReturn per unit of downside risk

+0.80

Omega ratioGain probability vs. loss probability

1.23

1.13

+0.10

Calmar ratioReturn relative to maximum drawdown

2.61

0.89

+1.73

Martin ratioReturn relative to average drawdown

6.76

1.66

+5.09

CLDX vs. GRBK - Sharpe Ratio Comparison

The current CLDX Sharpe Ratio is 1.12, which is higher than the GRBK Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of CLDX and GRBK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CLDX vs. GRBK - Drawdown Comparison

The maximum CLDX drawdown since its inception was -99.73%, roughly equal to the maximum GRBK drawdown of -99.29%. Use the drawdown chart below to compare losses from any high point for CLDX and GRBK.


Loading charts...

Drawdown Indicators


CLDXGRBKDifference

Max Drawdown

Largest peak-to-trough decline

-99.73%

-99.29%

-0.44%

Max Drawdown (1Y)

Largest decline over 1 year

-24.23%

-23.99%

-0.24%

Max Drawdown (3Y)

Largest decline over 3 years

-70.84%

-36.15%

-34.69%

Max Drawdown (5Y)

Largest decline over 5 years

-73.11%

-45.12%

-27.99%

Max Drawdown (10Y)

Largest decline over 10 years

-97.90%

-54.29%

-43.61%

Current Drawdown

Current decline from peak

-94.11%

-67.52%

-26.59%

Average Drawdown

Average peak-to-trough decline

-78.04%

-87.55%

+9.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.35%

12.77%

-3.42%

Volatility

CLDX vs. GRBK - Volatility Comparison

Celldex Therapeutics, Inc. (CLDX) has a higher volatility of 11.62% compared to Green Brick Partners, Inc. (GRBK) at 9.36%. This indicates that CLDX's price experiences larger fluctuations and is considered to be riskier than GRBK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CLDXGRBKDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.62%

9.36%

+2.26%

Volatility (6M)

Calculated over the trailing 6-month period

38.03%

24.69%

+13.34%

Volatility (1Y)

Calculated over the trailing 1-year period

56.82%

35.57%

+21.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

59.21%

42.87%

+16.34%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.95%

43.70%

+34.25%

Dividends

CLDX vs. GRBK - Dividend Comparison

Neither CLDX nor GRBK has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CLDX vs. GRBK - Financials Comparison

This section allows you to compare key financial metrics between Celldex Therapeutics, Inc. and Green Brick Partners, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M600.00M20222023202420252026
15.00K
455.99M
(CLDX) Total Revenue
(GRBK) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CLDX and GRBK have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CLDX has higher volatility (11.62%) compared to GRBK (9.36%). In terms of maximum drawdown, CLDX dropped -99.73% vs GRBK's -99.29%.

CLDX currently has the higher Sharpe Ratio (1.12 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CLDX and GRBK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer